Clinical Reviews in Allergy & Immunology

, Volume 33, Issue 1, pp 107-112

Recent Advances on Pathogenesis and Therapies in Systemic Sclerosis

  • Norihito YazawaAffiliated withDepartment of Dermatology, Faculty of Medicine, University of Tokyo Email author 
  • , Manabu FujimotoAffiliated withDepartment of Dermatology, Kanazawa University Graduate School of Medical Science
  • , Kunihiko TamakiAffiliated withDepartment of Dermatology, Faculty of Medicine, University of Tokyo

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Systemic sclerosis (SSc) is a systemic autoimmune disease characterized by extensive fibrotic changes in various organs, including skin and lung. Although the etiology of SSc remains unknown, three major abnormalities, abnormal humoral immunity, microvasculature, and fibroblast dysfunctions are considered to play important roles. Significant progress has been made in understanding the pathogenesis on SSc, and has been also providing clues to the treatment for this disease. This review summarizes recent advances on the pathogenesis and new therapeutic strategy for SSc.


Scleroderma Autoimmune diseases Therapy Pathogenesis B cell Fibroblast Pulmonary hypertension Cytokine Chemokine